🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT07275567
Active, not recruiting Observational

Data-driven Development of a Core Dataset for Difficult Airway Alerts

NCT07275567 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2019-04-01
Last updated
2025-12-10

Condition(s) studied

Airway ManagementIntubation; Difficult or FailedAirway Complication of Anesthesia

Study summary

Previous difficult airway management is the most accurate predictor of future difficulty. Consistent documentation is paramount for future airway planning, but requires reliable, reproducible and easily accessible information. Currently, anaesthesia alert cards are often based on analogue hard copies while they lack a clinically meaningful core data set allowing structured reproducible documentation and risk estimation. Further, existing alert cards are often inconsistently used and clear triggers for issuing of airway alert cards are widely undefined. The FingAIRprint project aims to develop a justifiable core data set using a data-driven approach in patients undergoing tracheal intubation with videolaryngoscopy or direct laryngoscopy, that is intended to be used for documentation of digital airway alerts.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients undergoing general anesthesia with tracheal intubation * Informed consent obtained * Age \> 18 years Exclusion Criteria: * Indication for intubation via a bronchoscope or awake intubation * Pregnant women

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Anesthesiology, Center for Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf Hamburg Germany

More Universitätsklinikum Hamburg-Eppendorf trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07275567 on ClinicalTrials.gov ↗ ← All trials in Germany